EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune cells harbor their own microbiome-derived metabolome: a new layer of immunometabolic regulation

Lisa Daley-Bauer, Luke Flantzer, Shuya Kyu, Anyce Godoy, Jaclyn Weinberg, Vincent C Marconi, Dean P Jones, Souheil-Antoine Younes

Frontiers in Immunology · 28.07.2026 · 17

DOI: 10.3389/fimmu.2026.1852583 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 28.07.2026. Verfasst von Lisa Daley-Bauer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Advanced Translational Research Unit (PATRU), Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta…. Hauptthemen laut MEDLINE: Metabolome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIA NIH HHS, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current models of microbiome, immune crosstalk center on extracellular receptor-mediated signaling, yet a critical observation challenges this paradigm: intracellular concentrations of gut-derived bacterial metabolites (GDBMs) in CD4 + T cells do not correlate with paired plasma levels, and it is intracellular, not circulating, GDBM burden that associates with metabolic pathway disruption and immune senescence. Here we propose the concept of an intracellular microbiome metabolome: a pool of aromatic GDBMs actively accumulated through carrier-mediated transport, retained through transcriptional suppression of efflux transporters, and integrated into host metabolic networks where metabolites directly engage intracellular senescence pathways. Using p-cresol sulfate (PCS) as a mechanistic prototype, we provide transcriptomic, proteomic, and metabolomic evidence implicating SLCO4A1/OATP4A1 as the primary entry transporter, whose suppression following PCS exposure creates a feed-forward intracellular retention loop. Once accumulated, PCS functions as a direct agonist of the aryl hydrocarbon receptor (AhR), engaging five downstream effector programs, TGF-β/SMAD signaling, Wnt/β-catenin reprogramming, Foxp3-dependent Treg induction, Notch dysregulation, and PTGS2/COX-2 induction with coordinate HPGD suppression driving PGE 2 excess via EP2/EP4/cAMP/CREM, that converge on mTOR suppression, glycolytic collapse, and mitochondrial dysfunction. This metabolic collapse in turn activates the integrated stress response (ISR) as a downstream consequence, driving p16/CDKN2A and p21/CDKN1A induction and the full immunometabolic signature of accelerated CD4 + T cell aging. The plasma intracellular dissociation explains why circulating GDBM levels have failed to predict immune outcomes in HIV-1 infection, chronic kidney disease, and aging, and positions intracellular GDBM quantification as the biologically relevant exposure metric. We discuss three therapeutic intervention layers: reduction of microbial metabolite production, blockade of SLCO4A1-mediated entry and efflux suppression, and targeting the AhR signaling axis with downstream metabolic and ISR consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomeGastrointestinal MicrobiomeHumansCresolsReceptors, Aryl HydrocarbonAnimalsOrganic Anion TransportersSignal TransductionSulfuric Acid Esters

Stichwörter der Autor:innen

P-cresol sulfateSLCO4A1/OATP4A1aryl hydrocarbon receptorgut-derived bacterial metabolitesintracellular microbiome metabolome

Substanzen

CresolsReceptors, Aryl HydrocarbonOrganic Anion Transporters4-cresol sulfateSulfuric Acid Esters

Autor:innen und Institutionen

  • Pathology Advanced Translational Research Unit (PATRU), Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, United States.
  • Division of Infectious Diseases Emory University School of Medicine and Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, United States.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States.

Förderung

  • NIAID NIH HHS
  • NIA NIH HHS
  • National Institute for Health and Care Research

Zitieren

APA

Daley-Bauer, L., Flantzer, L., Kyu, S., Godoy, A., Weinberg, J., Marconi, V. C., Jones, D. P., & Younes, S. A. (2026). Immune cells harbor their own microbiome-derived metabolome: a new layer of immunometabolic regulation. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1852583

Vancouver

Daley-Bauer L, Flantzer L, Kyu S, Godoy A, Weinberg J, Marconi VC, et al. Immune cells harbor their own microbiome-derived metabolome: a new layer of immunometabolic regulation. Frontiers in Immunology. 2026;17. doi:10.3389/fimmu.2026.1852583

BibTeX
@article{DaleyBauer2026,
  author = {Daley-Bauer, Lisa and Flantzer, Luke and Kyu, Shuya and Godoy, Anyce and Weinberg, Jaclyn and Marconi, Vincent C and Jones, Dean P and Younes, Souheil-Antoine},
  title = {Immune cells harbor their own microbiome-derived metabolome: a new layer of immunometabolic regulation},
  journal = {Frontiers in Immunology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fimmu.2026.1852583}
}
Kostenlos starten →